Agilent Technologies (A) Cash from Investing Activities (2009 - 2026)
Agilent Technologies' (A) quarterly Cash from Investing Activities came in at -$1.0 billion in Q3 2026, down 975.0% year-over-year from $117.9 million in Q3 2025, and down 1240.26% quarter-over-quarter from -$77.0 million in Q2 2026.
Analysis
Agilent Technologies (A) Cash from Investing Activities (2009 - 2026) Analysis & Trends
Agilent Technologies (A) has reported Cash from Investing Activities for 18 consecutive years, with -$1.0 billion the latest figure, recorded in Q3 2026.
- On a quarterly basis, Cash from Investing Activities fell 975.0% year-over-year to -$1.0 billion in Q3 2026; TTM through Jul 2026 was -$1.3 billion, a 2.7% decrease from a year earlier, with the FY2025 full-year figure at -$394.0 million, up 68.68% from the prior year.
- Cash from Investing Activities was -$1.0 billion for Q3 2026 at Agilent Technologies, down from -$77.0 million in the prior quarter.
- Over five years, Cash from Investing Activities peaked at -$40.0 million in Q4 2023 and troughed at -$1.0 billion in Q3 2026.
- A 5-year average of -$184.3 million and a median of -$94.0 million in 2025 frame the typical range for Cash from Investing Activities.
- Across the five-year window, Cash from Investing Activities sank 2285.0% in 2024 and soared 90.57% in 2025, its largest moves.
- Over 5 years, Cash from Investing Activities stood at -$110.0 million in 2022, then surged by 63.64% to -$40.0 million in 2023, then slumped by 2285.0% to -$954.0 million in 2024, then soared by 90.57% to -$90.0 million in 2025, then sank by 1046.67% to -$1.0 billion in 2026.
- The last three Cash from Investing Activities figures came in at -$1.0 billion (Q3 2026), -$77.0 million (Q2 2026), and -$93.0 million (Q1 2026), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | 164.00 Mn |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | -10.15 Bn |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | -1.03 Bn |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | -122.00 Mn |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | -3.51 Mn |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | -7.06 Mn |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | -66.70 Mn |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | -2.09 Mn |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | -7.74 Mn |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | -25.30 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | -1.03 Bn |
| Apr 30, 2026 | -77.00 Mn |
| Jan 31, 2026 | -93.00 Mn |
| Oct 31, 2025 | -90.00 Mn |
| Jul 31, 2025 | -96.00 Mn |
| Apr 30, 2025 | -114.00 Mn |
| Jan 31, 2025 | -94.00 Mn |
| Oct 31, 2024 | -954.00 Mn |
| Jul 31, 2024 | -100.00 Mn |
| Apr 30, 2024 | -109.00 Mn |
| Jan 31, 2024 | -95.00 Mn |
| Oct 31, 2023 | -40.00 Mn |
| Jul 31, 2023 | -89.00 Mn |
| Apr 30, 2023 | -77.00 Mn |
| Jan 31, 2023 | -104.00 Mn |
| Oct 31, 2022 | -110.00 Mn |
| Jul 31, 2022 | -73.00 Mn |
| Apr 30, 2022 | -76.00 Mn |
| Jan 31, 2022 | -79.00 Mn |
| Oct 31, 2021 | -59.00 Mn |